Publications by authors named "Daniel Laryea"

Claim this Profile
N
Novel activity of acriflavine against colorectal cancer tumor cells.
Saadia Hassan, Daniel Laryea, Haile Mahteme, Jenny Felth, Mårten Fryknäs

Cancer Sci· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the cytotoxic properties of the benzimidazole fungicides, benomyl and carbendazim, in human tumour cell lines and primary cultures of patient tumour cells.
Daniel Laryea, Joachim Gullbo, Anders Isaksson, Rolf Larsson, Peter Nygren

Anticancer Drugs· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the cytotoxic activity of the indoloquinoline alkaloid cryptolepine in human tumour cell lines and primary cultures of tumour cells from patients.
Daniel Laryea, Anders Isaksson, Colin W Wright, Rolf Larsson, Peter Nygren

Invest New Drugs· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats.
Gabor Lendvai, Irina Velikyan, Mats Bergström, Sergio Estrada, Daniel Laryea

Eur J Pharm Sci· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of 5-[(76)Br]bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour model.
Ivan Borbath, Vincent Grégoire, Mats Bergström, Daniel Laryea, Bengt Långström

Eur J Nucl Med Mol Imaging· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis